APA

Heim M., Sharifi M., Hilger R. A., Scheulen M. E., Seeber S. & Strumberg D. (20040323). Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006. : International journal of clinical pharmacology and therapeutics.

Chicago

Heim M, Sharifi M, Hilger R A, Scheulen M E, Seeber S and Strumberg D. 20040323. Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006. : International journal of clinical pharmacology and therapeutics.

Harvard

Heim M., Sharifi M., Hilger R. A., Scheulen M. E., Seeber S. and Strumberg D. (20040323). Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006. : International journal of clinical pharmacology and therapeutics.

MLA

Heim M, Sharifi M, Hilger R A, Scheulen M E, Seeber S and Strumberg D. Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006. : International journal of clinical pharmacology and therapeutics. 20040323.